المؤلفون: Zahra Kassam, H. MacKay, C. A. Buckley, S. Fung, M. Pintile, A. Oza, J. Brierley, C. Swallow, B. Cummings, J. J. Knox, J. Kim, R. Wong, L. Siu, R. Feld, J. Ringash

المصدر: Current Oncology; Volume 17; Issue 4; Pages: 34-41

مصطلحات موضوعية: adjuvant therapy, chemoradiation, gastric cancer, phase i study, cisplatin, 5-fluorouracil

وصف الملف: application/pdf

Relation: https://dx.doi.org/10.3747/co.v17i4.521

الاتاحة: https://doi.org/10.3747/co.v17i4.521

المؤلفون: J. J. Knox, D. Hedley, A. Oza, L. L. Siu, G. R. Pond, M. J. Moore

المساهمون: The Pennsylvania State University CiteSeerX Archives

المصدر: http://annonc.oxfordjournals.org/content/15/5/770.full.pdf.

وصف الملف: application/pdf

Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.493.1270; http://annonc.oxfordjournals.org/content/15/5/770.full.pdf

الاتاحة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.493.1270
http://annonc.oxfordjournals.org/content/15/5/770.full.pdf

المؤلفون: A M, Horgan, G, Darling, R, Wong, M, Guindi, G, Liu, D J, Jonker, J, Lister, W, Xu, H M, MacKay, R, Dinniwell, J, Kim, A, Pierre, Y, Shargall, T R, Asmis, O, Agboola, A J, Seely, J, Ringash, J, Wells, E C, Marginean, M, Haider, J J, Knox

المصدر: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 29(8)

مصطلحات موضوعية: Adult, Male, Indoles, Esophageal Neoplasms, Antineoplastic Agents, Chemoradiotherapy, Kaplan-Meier Estimate, Middle Aged, Neoadjuvant Therapy, Esophagectomy, Survival Rate, Withholding Treatment, Chemotherapy, Adjuvant, Antineoplastic Combined Chemotherapy Protocols, Sunitinib, Feasibility Studies, Humans, Female, Pyrroles, Esophagogastric Junction, Postoperative Period, Cisplatin, Neoplasm Recurrence, Local, Aged, Neoplasm Staging

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::7b986aa5ef2d71839a1c56467af5f6cc
https://pubmed.ncbi.nlm.nih.gov/26663741

المؤلفون: H K, Gan, B, Seruga, J J, Knox

المصدر: Current Oncology

مصطلحات موضوعية: second-line therapy, sunitinib, temsirolimus, Urologic Oncology, sorafenib, bevacizumab, everolimus, Renal cell carcinoma

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::0d7c527b2cdee69bd3d2958809d14eba
https://pubmed.ncbi.nlm.nih.gov/19478898

المؤلفون: J J, Knox, M J, Moore

المصدر: Seminars in urologic oncology. 19(3)

مصطلحات موضوعية: Male, Antineoplastic Agents, Hormonal, Antineoplastic Combined Chemotherapy Protocols, Palliative Care, Estramustine, Quality of Life, Humans, Pain, Prednisone, Prostatic Neoplasms, Suramin, Adenocarcinoma, Mitoxantrone

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::694e9ea802ff292a0c363225835bb516
https://pubmed.ncbi.nlm.nih.gov/11561988

المؤلفون: D. Y. Heng, W. Xie, M. M. Regan, T. Cheng, S. North, J. J. Knox, C. Kollmannsberger, D. McDermott, B. I. Rini, T. K. Choueiri

المصدر: Journal of Clinical Oncology. 27:5041-5041

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::05dab0e56b1bb38157ea885fc26aaa8c
https://doi.org/10.1200/jco.2009.27.15_suppl.5041

المؤلفون: A Manoukian, P J Rebstein, J J Knox, Richard M. Gronostajski

مصطلحات موضوعية: Chloramphenicol O-Acetyltransferase, TATA box, Genetic Vectors, Molecular Sequence Data, CAAT box, Biology, Transfection, Cell Line, Animals, Humans, Binding site, NFI Transcription Factors, Enhancer, Promoter Regions, Genetic, Molecular Biology, Transcription factor, Binding Sites, Nuclear factor I, Base Sequence, Chimera, Nuclear Proteins, Cell Biology, Y box binding protein 1, beta-Galactosidase, Molecular biology, DNA-Binding Proteins, CCAAT-Enhancer-Binding Proteins, Y-Box-Binding Protein 1, Research Article, HeLa Cells, Transcription Factors

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07c4cb14be9a676128d03437dac56977
https://europepmc.org/articles/PMC360121/

المساهمون: College of Medicine, Dept. of Internal Medicine, J. J. Knox, C. H. Barrios, T. M. Kim, T. Cosgriff, V. Srimuninnimit, K. Pittman, R. Sabbatini, S. Y. Rha, T. W. Flaig, R. D. Page, J. T. Beck, F. Cheung, S. Yadav, P. Patel, L. Geoffrois, J. Niolat, N. Berkowitz, M. Marker, D. Chen, R. J. Motzer, Rha, Sun Young

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma, Renal Cell/drug therapy, Cross-Over Studies, Everolimus/administration & dosage, Female, Humans, Indoles/administration & dosage, Kidney Neoplasms/drug therapy, Male, Middle Aged, Prognosis, Pyrroles/administration & dosage, Survival Analysis, Young Adult, everolimus, renal cell carcinoma, sequential targeted therapy, sunitinib

Relation: ANNALS OF ONCOLOGY; J00171; OAK-2017-05335; https://ir.ymlib.yonsei.ac.kr/handle/22282913/160952; T201703713; ANNALS OF ONCOLOGY, Vol.28(6) : 1339-1345, 2017

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/160952
https://doi.org/10.1093/annonc/mdx075

المساهمون: D. Y. C. Heng, T. K. Choueiri, B. I. Rini, J. Lee, T. Yuasa, S. K. Pal, S. Srinivas, G. A. Bjarnason, J. J. Knox, M. MacKenzie, U. N. Vaishampayan, M. H. Tan, S. Y. Rha, F. Donskov, N. Agarwal, C. Kollmannsberger, S. North, L. A. Wood, Rha, Sun Young

المصدر: T201404195.pdf

مصطلحات موضوعية: Antibodies, Monoclonal, Humanized/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Bevacizumab, Brain Neoplasms/drug therapy, Brain Neoplasms/mortality, Brain Neoplasms/secondary, Carcinoma, Renal Cell/drug therapy, Renal Cell/mortality, Renal Cell/secondary, Clinical Trials as Topic, Disease-Free Survival, Eligibility Determination, Humans, Indoles/administration & dosage, Kaplan-Meier Estimate, Karnofsky Performance Status, Kidney Neoplasms/drug therapy, Kidney Neoplasms/mortality, Kidney Neoplasms/pathology, Middle Aged, Molecular Targeted Therapy, Niacinamide/administration & dosage, Niacinamide/analogs & derivatives, Phenylurea Compounds/administration & dosage, Pyrimidines/administration & dosage, Pyrroles/administration & dosage, Sulfonamides/administration & dosage

وصف الملف: 149~154

Relation: ANNALS OF ONCOLOGY; J00171; OAK-2014-02524; https://ir.ymlib.yonsei.ac.kr/handle/22282913/138257; T201404195; ANNALS OF ONCOLOGY, Vol.25(1) : 149-154, 2014

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/138257
https://doi.org/10.1093/annonc/mdt492

المساهمون: J J Ko, T K Choueiri, B I Rini, J L Lee, N Kroeger, S Srinivas, L C Harshman, J J Knox, G A Bjarnason, M J MacKenzie, L Wood, U N Vaishampayan, N Agarwal, S K Pal, M H Tan, S Y Rha, T Yuasa, F Donskov, A Bamias, D Y C Heng, Rha, Sun Young

المصدر: T201404191.pdf

مصطلحات موضوعية: Aged, 80 and over, Antineoplastic Agents/administration & dosage, Antineoplastic Agents/adverse effects, Carcinoma, Renal Cell/drug therapy, Renal Cell/pathology, Clinical Trials as Topic, Disease-Free Survival, Female, Humans, Male, Middle Aged, Molecular Targeted Therapy, Neoplasm Metastasis, Proportional Hazards Models, Survival Analysis, TOR Serine-Threonine Kinases/antagonists & inhibitors, Treatment Outcome, Vascular Endothelial Growth Factor A/antagonists & inhibitors, metastatic renal cell carcinoma, targeted molecular therapy, outcomes assessment, overall survival, progression-free survival, mTOR inhibitor, VEGF inhibitor, benchmarks, international metastatic renal cell cancer database consortium

وصف الملف: 1917~1922

Relation: BRITISH JOURNAL OF CANCER; J00406; OAK-2014-02520; https://ir.ymlib.yonsei.ac.kr/handle/22282913/138253; T201404191; BRITISH JOURNAL OF CANCER, Vol.110(8) : 1917-1922, 2014

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/138253
https://doi.org/10.1038/bjc.2014.25